| p53 signaling pathway |
2.36 |
0.00e+0 |
63/73 (86.3%) |
IGFBP3;DDB2;CDKN1A;...
|
| HIF-1 signaling pathway |
2.21 |
0.00e+0 |
105/109 (96.33%) |
ALDOC;SLC2A1;CDKN1A;...
|
| MicroRNAs in cancer |
2.20 |
0.00e+0 |
146/310 (47.1%) |
CDKN1A;PDGFA;VEGFA;...
|
| TNF signaling pathway |
2.11 |
0.00e+0 |
103/112 (91.96%) |
TNFAIP3;JUNB;IL1B;...
|
| Fructose and mannose metabolism |
2.01 |
4.34e-3 |
30/33 (90.91%) |
ALDOC;PFKP;HK2;...
|
| Transcriptional misregulation in cancer |
2.01 |
3.62e-3 |
158/192 (82.29%) |
IGFBP3;DDB2;CDKN1A;...
|
| Prostate cancer |
1.99 |
3.10e-3 |
93/97 (95.88%) |
TGFA;CDKN1A;PDGFA;...
|
| PI3K-Akt signaling pathway |
1.99 |
2.71e-3 |
317/354 (89.55%) |
TGFA;CDKN1A;PDGFA;...
|
| Focal adhesion |
1.94 |
4.82e-3 |
180/201 (89.55%) |
PDGFA;FN1;VEGFA;...
|
| Melanoma |
1.93 |
4.34e-3 |
68/72 (94.44%) |
DDB2;CDKN1A;PDGFA;...
|
| ECM-receptor interaction |
1.91 |
3.95e-3 |
80/88 (90.91%) |
FN1;COL4A1;TNC;...
|
| Bacterial invasion of epithelial cells |
1.91 |
3.62e-3 |
59/77 (76.62%) |
FN1;MET;CAV2;...
|
| Small cell lung cancer |
1.90 |
3.34e-3 |
90/92 (97.83%) |
DDB2;CDKN1A;FN1;...
|
| AGE-RAGE signaling pathway in diabetic complications |
1.90 |
3.10e-3 |
97/100 (97%) |
EGR1;SERPINE1;FN1;...
|
| Relaxin signaling pathway |
1.85 |
5.06e-3 |
114/129 (88.37%) |
VEGFA;EGFR;COL4A1;...
|
| Thyroid cancer |
1.84 |
4.75e-3 |
36/37 (97.3%) |
DDB2;CDKN1A;GADD45B;...
|
| Bladder cancer |
1.84 |
4.47e-3 |
40/41 (97.56%) |
CDKN1A;VEGFA;EGFR;...
|
| Glioma |
1.83 |
6.03e-3 |
67/75 (89.33%) |
TGFA;DDB2;CDKN1A;...
|
| Central carbon metabolism in cancer |
1.82 |
7.42e-3 |
67/70 (95.71%) |
SLC2A1;PFKP;HK2;...
|
| Pancreatic cancer |
1.78 |
1.14e-2 |
75/76 (98.68%) |
TGFA;DDB2;CDKN1A;...
|
| Malaria |
1.77 |
1.39e-2 |
44/50 (88%) |
MET;IL1B;CXCL8;...
|
| Axon guidance |
1.76 |
1.43e-2 |
151/182 (82.97%) |
EPHA2;MET;BMP7;...
|
| Proteoglycans in cancer |
1.76 |
1.37e-2 |
172/205 (83.9%) |
CDKN1A;FN1;VEGFA;...
|
| Colorectal cancer |
1.76 |
1.40e-2 |
84/86 (97.67%) |
TGFA;DDB2;CDKN1A;...
|
| African trypanosomiasis |
1.75 |
1.43e-2 |
32/37 (86.49%) |
IL1B;FAS;PRKCA;...
|
| Rheumatoid arthritis |
1.74 |
1.67e-2 |
78/93 (83.87%) |
VEGFA;IL1B;IL1A;...
|
| TGF-beta signaling pathway |
1.74 |
1.61e-2 |
81/94 (86.17%) |
INHBA;TGIF1;ID2;...
|
| Endometrial cancer |
1.73 |
1.70e-2 |
56/58 (96.55%) |
DDB2;CDKN1A;GADD45B;...
|
| Non-small cell lung cancer |
1.73 |
1.65e-2 |
70/72 (97.22%) |
TGFA;DDB2;CDKN1A;...
|
| Pathways in cancer |
1.72 |
1.82e-2 |
474/531 (89.27%) |
TGFA;DDB2;SLC2A1;...
|
| Ascorbate and aldarate metabolism |
-1.69 |
2.46e-2 |
15/30 (50%) |
KL;AKR1A1;ALDH2;...
|
| Spliceosome |
-1.75 |
1.77e-2 |
101/150 (67.33%) |
MAGOH;RBMXL2;HSPA1L;...
|
| Folate biosynthesis |
-1.75 |
1.97e-2 |
23/26 (88.46%) |
MOCS2;ALPG;PCBD1;...
|
| Proteasome |
-1.78 |
1.58e-2 |
44/46 (95.65%) |
PSMA6;PSMB3;PSMC1;...
|
| Tyrosine metabolism |
-1.80 |
1.57e-2 |
30/36 (83.33%) |
DCT;HGD;AOC3;...
|
| Pyruvate metabolism |
-1.82 |
1.83e-2 |
41/47 (87.23%) |
AKR1A1;ME2;ALDH2;...
|
| RNA transport |
-1.89 |
5.07e-3 |
128/186 (68.82%) |
GEMIN8;EIF2B5;SEC13;...
|
| Fatty acid degradation |
-1.89 |
6.34e-3 |
40/43 (93.02%) |
EHHADH;ACOX1;ALDH2;...
|
| Citrate cycle (TCA cycle) |
-1.92 |
5.63e-3 |
30/30 (100%) |
PDHA1;IDH3G;ACO2;...
|
| Ribosome biogenesis in eukaryotes |
-1.92 |
4.22e-3 |
52/108 (48.15%) |
GTPBP4;NXF1;GNL2;...
|
| Aminoacyl-tRNA biosynthesis |
-2.05 |
0.00e+0 |
15/66 (22.73%) |
CARS2;IARS2;SARS2;...
|
